Search Results - Alberto Alfonso Pimentel-Rentería
- Showing 1 - 1 results of 1
-
1
Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study by Alberto Alfonso Pimentel-Rentería, David Francisco Cantú de León, Eliseo Neftalí De la Cruz, David Suárez, Manuel Rodulfo Segura, José Gustavo Núñez, Livan Delgado-Roche
Published in Frontiers in Drug Discovery (2025-05-01)Get full text
Article
